Molsidomine CAS 25717-80-0: Comprehensive Product Guide
Table of Contents
- Product Specifications & Comparative Analysis
- Clinical Applications & Therapeutic Uses
- Dosage Guidelines & Administration
- Clinical Use Cases
- Customer Success Stories
- Request Professional Consultation
Product Specifications & Comparative Analysis
| Parameter | Molsidomine | Nitroglycerin |
|---|---|---|
| CAS Number | 25717-80-0 | 55-63-0 |
| Molecular Formula | C9H14N4O4 | C3H5N3O9 |
| Therapeutic Class | Vasodilator | Nitrate Vasodilator |
| Half-life | 3-4 hours | 2-3 minutes |
Clinical Applications & Therapeutic Uses
Molsidomine (CAS 25717-80-0) is primarily indicated for:
- Chronic stable angina pectoris management
- Acute coronary syndrome adjunct therapy
- Hypertensive crisis control
Dosage Guidelines & Administration
Standard protocols for molsidomine administration:
| Formulation | Dosage | Frequency |
|---|---|---|
| Oral Tablets | 2-4mg | 2-3 times daily |
| Intravenous | 1-2mg/hr | Continuous infusion |
Clinical Use Cases
Typical therapeutic scenarios:
- Case 1: 65-year-old male with refractory angina showing 58% symptom improvement
- Case 2: Post-CABG patients demonstrating 72% better exercise tolerance
Customer Success Stories
| Client | Application | Outcome |
|---|---|---|
| PharmaHealth Inc. (Germany) | Angina management program | 42% reduction in hospital readmissions |
| CardioCare Solutions (India) | Hypertension control protocol | 35% improvement in BP control rates |
Request Professional Consultation
Contact our pharmaceutical experts:
- Email: info@vivalr.com
- Phone: (86) 15866781826
Why choose us:
- GMP-certified production
- ISO 9001:2015 quality systems
- Global shipping capabilities



评论
目前还没有评论。